HE OVERLAPPING activities of the various hematopoietic growth factors in vitro, both in terms of the populations of cells on which they act and also their effects on those cells, have raised the possibility that there may be redundancy amongst these factors in vivo.' One such group of hematopoietic regulators is that influencing the proliferation and function of cells of the monocyte/macrophage lineage, which include granulocyte-macrophage colonystimulating factor (GM-CSF)'.2 and macrophage colonystimulating factor (M-CSF, also known as CSF-1).'.3.4 A definitive way to determine if redundancy exists amongst hematopoietic regulators in vivo is to study mice deficient in individual factors and combinations of factors.'. 5 In a previous study, we generated mice deficient in GM-CSF by disruption of the GM-CSF gene using gene targeting in embryonal stem cells6 GM-CSF-deficient mice have relatively unperturbed baseline hematopoiesis in terms of the number of circulating hematopoietic cells and progenitor cell levels in hematopoietic organs. However, GM-CSFdeficient mice have an invariable but nonfatal lung disorder characterized by accumulation of alveolar material, and vulnerability to pulmonary infections with a range of opportunistic bacterial and fungal organisms, showing an irreplaceable role for GM-CSF in pulmonary physiology?
Mice deficient in M-CSF arose as a result of the spontaneously occurring osteopetrotic (op) mutation, which is a point mutation in the M-CSF gene that results in trucated and inactive M-CSF.7-9 M-CSF-deficient mice are characterized by osteopetrosis and an age-dependent macrophage defi~i e n c y ,~"~ and have been instructive in defining unique roles for M-CSF in hematopoiesis and bone development in vivo. 13 It is possible that the consequences of deficiency of one factor may be ameliorated in part by compensatory effects of another factor. For example, the pulmonary consequences of GM-CSF deficiency may be ameliorated by compensatory effects of other hematopoietic growth factors. Although the particularly involving Gram-negative bacteria. Neutrophilia consistently accompanies pulmonary infections, and some older GM-/-M-/-mice have polycythemia. Survival of GM-/-M-/-mice is significantly reduced compared with mice deficient in either factor alone, and all GM-/-M-/ -mice have broncho-or lobar-pneumonia at death. These observations indicate that in vivo, M-CSF is involved in modulating the consequences of GM-CSF deficiency in the lung. Interestingly, GM-/-M-/-mice have circulating monocytes at levels comparable with those in M-CSF-deficient mice and the diseased lungs of all GM-/-M-/-mice contain numerous phagocytically active macrophages, indicating that in addition t o GM-CSF and M-CSF. other factors can be used for macrophage production and function in vivo. 0 1994 by The American Society of Hematology.
demonstration of elevated levels of hematopoietic growth factors remaining in GM-CSF-deficient mice would provide indirect evidence for this hypothesis, a more definitive approach is to combine deficiency of a second hematopoietic growth factor with GM-CSF deficiency. This genetic approach may result in new or exacerbated phenotypic characteristics in addition to those evident in animals deficient in either factor alone, providing insights to distinguish between the unique and overlapping in vivo roles of the factors in question.
Among the factors that remain in GM-CSF-deficient mice, M-CSF is of particular interest, because of its lineagespecific role in augmenting macrophage production and function in and because large, phagocytically active macrophages are a prominent feature of the pulmonary pathology in GM-CSF-deficient mice.6 Similarly, it is of interest to define the extent to which GM-CSF may be involved in compensating for M-CSF deficiency. Therefore, we interbred GM-CSF-deficient mice with M-CSF-deficient os-PCR-based strategy for defining allelic status at the M-CSF locus was devised. By comparison of the murine cDNA sequence'".'' with the published incomplete genomic structure of the human M-CSF gene,'""' it was predicted that the op point mutation lay in an exon homologous to human exon 3. Primers complimentary to murine cDNA sequences were used to amplify a fragment from murine genomic DNA corresponding to the intron S' of this exon, and 300 bp of the 3' end of this 1.6-kb PCR-generated fragment was sequenced (G.J.L., unpublished data, March 1993). The diagnostic PCR paired a S' sense primer corresponding to sequences from this intronic pmol/L of each dNTP, 12.5 ng of each primer, and 1.5 U of Taq polymerase. These primers generated a PCR product of 195 bp or 196 bp, dependent on whether or not the thymidine base insertion of the op mutation was present in template DNA. A 2-bp mismatch in the 3'-antisense primer (underlined), introduced a second Bg/ I site into PCR product spanning the extra base of the op mutation that was absent from PCR product from wild-type template. PCR product was digested with Bg/ I (10 U120 pL PCR). which cut at the intronic BgI I site generating a 96-bp product in all cases (confirming restriction enzyme activity in each PCR reaction), and generating either a 99-bp fragment diagnostic for wild-type template, or 70-bp and 30-bp fragments indicative of the extra base in PCR product generated from op template. These small fragments were separated by electrophoresis in 4% Metaphor agarose gels (FMC BioProducts, Rockland, ME) and visualized by ethidium-staining. Thus, heterozygous Cop/+, M+/-), homozygous (op/op. M-/-), and wild-type (M+/+) mice could be distinguished on the basis of this diagnostic PCR alone (Fig I) . Hematologic analysis. Hemoglobin, total leukocyte, and platelet levels in peripheral blood were determined on I :4 dilutions of eyebleed samples using a Sysmex K-I OOO automated counter (Toa Medical Electronics CO Ltd. Kobe, Japan), and manual 100-cell leukocyte differential counts performed on May-Griinwald/Giemsa-stained smears. To confirm the presence of monocytes, some fresh blood smears were stained with fluorescein isothiocyanate-conjugated F41 80 antibody (Serotec MCA497F. Oxford, England).'' Histologic ana/ysis. For histologic analysis. formalin-fixed paraffin-embedded sections of mouse organs were stained using standard techniques with hematoxylin and eosin (H&E). and selected sections with the Grocott methenamine silver, period-acid-Schiff (PAS), toluidine blue, and Gram stains. Bones were decalcified before mounting and sectioning.
For electron microscopy. random strips of fresh lung tissue were Survival data were analyzed by constructing KaplanMeier survival curves and compared using the Mantel-Cox statistic. There was no difference between the survival of 14 GM+/+"/-and I2 GM+/"-/-mice (P = .23); therefore, these data were pooled for survival comparisons. Other data were compared using the Chi-squared test and unpaired t-test as appropriate. Comparisons of peripheral blood hematologic data were confined to groups of mice of different genotypes sampled on the same day. A P value of <.05 was regarded as statistically significant.
RESULTS

Viability and fertility of GM-/-M-/-
mice. From initial interbreeding of GM+/-M+/-mice, litters of 7 2 2 pups (n = 15) were born. GM-CSF allelic status was determined by PCR analysis:
and M-CSF allelic status by the diagnostic PCR developed for this purpose (Fig 1) . The nine possible genotypes were represented in approximately the expected Mendelian ratios at weaning of 144 genotyped pups ( Table l) . In particular, GM-/-M-/-were not significantly under-represented relative to wild-type mice, indicating that GM-/-M-/-mice were viable and there was no major fetal or neonatal loss, although amongst this genotype, male mice were over-represented ( Table 1) . Subsequent interbreeding of GM-/-M+/-mice generated litters of which 25/164 (15%) of pups were GM-/"-/-; this was significantly fewer than expected ( P < .OS), and as observed in crosses of heterozygous parents, there was again a trend toward male preponderance (19/25) ( P < .l). GM-/-M-/ -males were fertile; one such male mated with a GM-/ -M+/-female has sired five litters of 5 ? 3 pups. In view of the difficulties experienced by others: we have not attempted to breed from M-/-females, regardless of GM-CSF status. Survival of GM-/-"/-was compared with that of all other toothless mice (GM+/-M-/-and GM+/+"/-), mice deficient only in GM-CSF (GM-/-M+/+), and wildtype (GM+/+M+/+) mice. All toothless (M-/-) mice had significantly reduced survival compared with wild-type and GM-CSF-deficient littermates, regardless of whether they were only M-CSF deficient, or were also GM-and M-CSF deficient (Fig 2) . Median survivals were: GM+/+M+/+ and GM-/-M+/+, not attained with follow-ups in excess of 300days;GM+/?M-/-,231days(n = 26);GM-/-M-/ -, 71 days (n = 38). The median survival of GM+/+"/ -and GM+/"-/-mice was significantly shorter than that of GM+/+M+/+ mice (P = .02), and that of GM-/ -M-/-mice was significantly shorter than that of other M-/-mice (P = .02) (Fig 2) . The difficulties with nutrition of toothless GM+/+ or GM+/-mice contributed to the death of most animals of these genotypes, although one GM+/+"/-mouse died of acute lobar pneumonia at 231 days, and three were killed for incidental reasons (snout abscess [88 days], an abdominal mass which proved to be a hernia [l17 days], and glossitis [ 118 days]). In contrast, acute broncho-or lobar-pneumonia contributed to the death of most GM-/"-/-mice (see below); at histologic examination of 19 GM-/-M-/-mice that died or were killed at ages from 24 days to 324 days because of apparent illness, all had severe lung disease and acute lobar pneumonia at the time of death; some of the mice were killed because of apparent distress were tachypnoeic, suggesting that the lung pathology in these mice was significantly compromising pulmonary function.
Hematologic analysis of GM-/"-/-mice. Histologic examination of the hematopoietic organs of GM-/ -M-/-showed marked hypoplasia of femoral marrow in the severely osteopetrotic bones of young mice (Fig 3A) , but in older mice, mmow cellularity had increased, although the bone architecture remained abnormal (Fig 3B) . Granulopoiesis was prominent in the marrow, and megakaryocyte numbers appeared normal (Fig 3C) . There was active extramedullary hematopoiesis in the spleens of all GM-/-"/ -animals. Hepatic foci of extramedullary hematopoiesis were very infrequent in adult GM-/"-/-mice. In the peripheral blood, hemoglobin levels of GM-/ -M-/-mice were significantly elevated in groups of mice analyzed at 29 to 35,46 to 77, and 124 to 170 days of age ( Table 2) , and this was accompanied by polycythemia in the older GM-/-M-/-mice relative to GM+/+M+/+ mice, although in this group., GM-/-M-/-mice red blood cell Days levels were not significantly higher than GM+/+"/-mice. Platelet levels of GM-/-M-/-mice tended to be lower than for mice of other genotypes, although the differences were not marked.
There were consistent perturbations of peripheral blood leukocyte populations in GM-/-M-/-mice. A relative lymphopenia was evident in GM-/-M-/-mice of all ages (Table 2) , although the degree of lymphopenia was not more marked than that which is typical for GM+/+"/-mice ( Table 2) ." GM-/-M-/-mice (138 to 170 days) had significantly elevated neutrophil levels compared with agematched mice deficient in either factor alone ( Table 2 ). The propensity to neutrophilia was apparent at all ages, although statistical significance was not always attained (Table 2) . Monocytes were present in the peripheral blood of GM-/ -M-/-mice of all ages (Table 2 and Fig 3D) , but levels were not consistently different to GM+/+M+/+, GM-/ -M+/+, or GM+/+"/-mice. The presence of circulating monocytes in GM-/-"/-mice was confirmed by F41 80 immunostaining of blood films (Fig 3E) . There were no consistent differences in levels of eosinophils in GM-/ -M-/-mice (the 157-day GM+/+M+/+ mice in Table 2 had atypically elevated and varied eosinophil levels).
In the tissues, leukocytes were evident in significant numbers. Despite the lymphopenia in GM-/"-/-mice relative to GM+/+M+/+ mice, a perivascular lymphoid infiltrate characterized GM-/-M-/-lung pathology, and was similar in distribution to that seen in GM-/"+/+ mice (Fig 3F) ? Neutrophils localized to sites of infection, because all GM-/-M-/-examined histologically had acute multifocal bronchopneumonia containing many neutrophils in the inflammatory exudate (Fig 3G) . The diseased lungs of older GM-/-M-/-mice contained large numbers of alveolar macrophages (Fig 3H) , indicating that tissue macrophages were available for host defenses. These alveolar macrophages had abundant foamy cytoplasm with numerous -M-/-, P < .0001; GM+/+"/ cytoplasmic particles of diastase-resistant PAS-positive material (Fig 31) , indicating that these particles were likely to be phagocytozed material rather than glycogen granules. On toluidine blue-stained spleen sections, the frequency of mast cells was 2 to 7/mm2. In the lungs, mast cells were most common in connective tissue near larger vessels and bronchi and near the serosal surface. Although numbers of pulmonary mast cells were not clearly increased, some aggregates of 10 to 20 mast cells were observed in mediastinal connective tissue of GM-/-M-/-mice (Fig 35) . Characterization of the pulmonary disease in GM-/ -M-/-mice. Detailed observations made on lungs from
19 GM-/-M-/-mice form the basis of this description of the lung pathology of GM-/-"/-mice. For comparative evaluations with the lung pathology in GM-/"+/+ mice, control sections were selected from the histology library from over 50 age-matched GM-/-M+/+ mice.' The lungs of 14 op/op (GM+/+"/-) mice (35 to 324 days) and 3 GM+/-M-/-mice (35 to 117 days) showed no consistent abnormal features, although one 321-day GM+/+"/-mouse was killed because it became unwell had acute lobar pneumonia.
Within the lungs of individual GM-/-"/-mice, an extensive range of pathologic processes was evident (eg, Fig  4A shows adjacent areas of bronchopneumonia, perivascular lymphoid hyperplasia, and alveoli containing eosinophilic material without inflammatory cells). Although the lungs of GM-/-M-/-mice had many histologic features seen with the lung disease previously observed in GM-CSF-deficient mice,' there were also some prominent differences, particularly in the extent of alveolar material accumulating, the prevalence and severity of acute pneumonic consolidation, and the incidence of documented microbial infection.
An invariable feature of the lungs of GM-/-M-/-mice was the presence of a granular, eosinophilic material within alveoli. This material accumulated with age and was already For personal use only. on September 24, 2017. by guest www.bloodjournal.org From extensive by 40 days of age. In some areas it was particulate (Fig 4B) , but in other areas it was confluent and contained clefts typical of lipid accumulation (Fig 4C) . The alveolar material was PAS-positive and diastase-resistant ( Figs 4C and 31). Particularly in mice younger than 40 days, the amount and extent of granular alveolar material was greater than in age-matched GM-/-M+/+ mice.
A lymphoid infiltrate, such as typifies the lung pathology of GM-/"+/+ mice,6 also occurred in these mice, with a marked perivascular rather than peribronchial distribution ( Figs 4A and 3F) . In GM-/-M-/-lungs the lymphoid infiltrate was a less prominent aspect of the pathologic process than the acute inflammatory alveolar exudate containing neutrophils, in contrast to GM-/-M+/+ lungs, where the converse was true.
A major feature of the lungs of all GM-/-M-/-mice was acute pneumonic consolidation, which was both more prevalent and markedly more extensive than in GM-/-M+/ + mice. Most typically, numerous discrete foci of acute bronchopneumonia occurred throughout all of the GM-/ -M-/-lungs examined (eg, Figs 4D and 3G) , including in lungs of mice that were not distressed but were killed for other experiments. In the lungs examined from GM-/-M-/ -mice that died, the pneumonia was more extensive, often showed a lobar pattern, and was often bilateral. Acute lung abscesses were found in 2/19 mice (ages 48 and 205 days) (eg, Fig 4E) . The abscesses contained neutrophil-rich pus and acute inflammatory cells predominated within the poorly organized walls, although there was a zone of macrophages up to 3 cells deep (Fig 4F) .
In the lungs of young (540 days) GM-/-M-/-mice, alveolar macrophages were sparse compared with agematched GM-/-M+/+ mice, but in older GM-/"-/-mice (>70 days), large alveolar macrophages with foamy cytoplasm were abundant (Fig 3, H and I) . Some alveolar macrophages were embedded in homogenous eosinophilic inflammatory exudate. Most macrophages were mononucleated, but binucleated forms occurred (Fig 3H) .
Bacteria, predominantly Gram-negative bacilli, were shown by Gram stain of lung sections of 11/19 GM-/-M-/ -mice (eg, Fig 4G) . A variety of bacteria was isolated by microbiologic cultures of 717 samples of lung tissue, 5 of which were obtained immediately on killing an animal, and 2 of which were processed immediately after postmortem sampling of dead mice. The bacteria isolated were: Klebsiella oxytoca (3), Pasteurella pneumotropica (2), Pasteurella hemolytica (l), and a mixed infection with Escherichia coli and u-hemolytic streptococci (1); these bacteria were recovered in significant numbers as a pure growth and were seen in Gram stains of tissues submitted for microbiologic analysis. One GM-/-M-/-mouse was killed because it developed a facial abscess tracking into the orbit, from which Streptococcal spp. were isolated. The histologic and microbiologic analyses demonstrated bacterial pneumonia to be more prevalent in GM-/-M-/-lungs than was observed in GM-/-M+/+ lungs from mice held contemporaneously in the same room of a conventional animal house. 6 No fungal organisms were cultured from specimens from GM-/-M-/ -lungs, and there was no histologic evidence of fungal pathogens among 19 GM-/-M-/-lung sections surveyed by Grocott and PAS stains. In particular, there were no foci of infection with the fungal agent identified histologically, such as we have observed in some GM-/"+/+ lungs examined in a similar manner. 6 Electron microscopy showed aggregates of fibrillary material and numerous type-C lamellar bodiesz3 within alveoli (Fig SA) , similar to those seen in GM-/-M+/+ lungs.6 The fibrillary alveolar material was comprised of aggregates of fibrils spaced 49 nm apart, each fibril having four axial ribs on transverse section ( Fig SB) ; there was a tendency for fibrils to stack in an orderly array. Large alveolar macrophages could be readily identified by their size, nuclear mor- 
, alveolar location, and surface microvilli. Many large alveolar macrophages contained numerous phagocytosed type-C lamellar bodies within their cytoplasm (eg, Fig  5A shows a macrophage 18 X 14 pm containing at least 34 type-C lamellar bodies). Some alveolar macrophages also contained amorphous lipid vacuolesx and well-demarcated long linear crystalloid clefts within their cytoplasm (Fig SD) . Such clefts were also evident within some alveoli. The appearances of these clefts were typical of those seen in association with cholesterol or cholesterol esters (J.M. Papadimitriou, personal communication, April 1994).
DISCUSSION
Analysis of mice deficient in hematopoietic growth factors provides a basis for determining the role of these factors in regulating physiologic process in vivo. GM-CSF and M-CSF are two hematopoietic growth factors that are both implicated in regulating the production and function of cells of the monocyte/macrophage lineage. Mice deficient in each of these factors exist and have characteristic but dissimilar phenotypic feature^.^"^ To investigate the impact of combined deficiency of these two major regulators of cells of the monocyte/macrophage lineage, we generated mice deficient in both factors by interbreeding. Analysis of these doubly deficient mice showed a number of interesting observations.
Despite lacking both GM-CSF and M-CSF, which have been regarded as two of the major factors influencing the production and differentiation of monocytes and macrophages, GM-/-M-/-mice still have circulating monocytes and tissue macrophages, indicating that at least one other factor can be used for monocyte/macrophage production in vivo. Among the factors that may be supporting monocyte and macrophage production in the absence of both GM-CSF and M-CSF, interleukin-3 (IL-3) is a potential candidate.'.I3 The demonstration of increased IL-3 production by tissues from GM-/-M-/-in vivo and in vitro would 33 support this notion. The net effect of combined GM-CSF and M-CSF deficiency on L -3 production is difficult to predict from studies on mice deficient in the individual factors: increased induced release of GM-CSF and IL-3 were shown in op/op mice,' but we observed reduced L -3 levels in spleen-conditioned media made from splenocytes from GM-CSF-deficient mice.6 An issue complicating the interpretation of this type of analysis is that GM-/-M-/-mice consistently have a granulocytosis, which may reflect an infection-related granulopoietic growth factor response to pulmonary infections, and levels of granulopoietic growth factors may be altered for this reason alone. Similar considerations apply to the other factors potentially compensating for combined M-CSF and GM-CSF deficiency, such as IL-
1.
Of course, the compensatory role of L -3 or any other factor could potentially be assessed more directly by superimposing deficiency of a third factor on combined GM-CSF and M-CSF deficiency.
It will be of interest to assess progenitor and stem cell levels of all hematopoietic lineages in the marrow and spleen of GM-/-M-/-mice. Such an analysis will complement studies of factor production in GM-/"-/-mice by giving insight at a cellular level into the mechanisms underlying the peripheral blood changes, including the lymphopenia and tendencies to polycythemia and slightly reduced platelet levels. The polycythemia is of particular interest, as it may be driven in part by increased erythropoietin production secondary to hypoxia, reflecting the severity of the lung disease, although this hypothesis requires direct evaluation.
Our analysis shows that the typical GM-CSF-deficiency lung disease, a form of alveolar proteinosis,6 is exacerbated by concomitant M-CSF deficiency. In particular, in our conventional animal house, M-CSF deficiency transforms the nonfatal GM-CSF-deficiency pulmonary disease into an often fatal illness, primarily caused by an increased incidence and seventy of bacterial acute pneumonia. We have previously suggested that the accumulation of surfactant phospholipid and proteins may be the primary intrinsic defect in For personal use only. on September 24, 2017. by guest www.bloodjournal.org From the alveolar proteinosis syndrome characterizing GM-CSFdeficient mice, and that infection is a secondary event. ' We have further evidence in support of this hypothesis: in GM-CSF-deficient mice reared in cleaner isolated environments, the initial accumulation of alveolar material still occurs, but without the pathologic features such as perivascular lymphocytic infiltrates and focal bronchopneumonia that invariably occur in GM-CSF-deficient mice raised concurrently in a conventional animal house environment (G.J.L., unpublished data, January 1994). To evaluate the impact of infection on the pulmonary pathology and survival of mice with combined GM-CSF and M-CSF deficiency, it will be necessary to reassess these parameters by studying experimentally induced infections in animals reared in a gnotobiotic facility.
Our observations also show that M-CSF-dependent cells contribute to pulmonary host defenses in vivo, at least in the face of GM-CSF deficiency. We hypothesize that the exacerbation of the GM-CSF lung disease by superimposed M-CSF deficiency may be caused in part by a further impairment in phagocyte function or reduction in their numbers, altering the balance of alveolar phospholipid and protein production or clearance. The observation that M-CSF-deficient mice do not have consistent pulmonary pathology although they have reduced numbers of alveolar macrophagesz5 lends support to this hypothesis. It will be interesting to enumerate alveolar macrophages in GM-/ -M-/-mice. Although our observations unequivocally implicate M-CSF and M-CSF-dependent cells as pivotally important in ameliorating the pulmonary consequences of GM-CSF deficiency, they do not prove that M-CSF is compensating for GM-CSF deficiency. Compensation by M-CSF for GM-CSF deficiency implies that M-CSF production in GM-CSF-deficient mice occurs at supraphysiologic levels, compared with levels of M-CSF production in wild-type mice. It is also of interest that the infections in GM-/-M-/ -mice are not controlled despite the presence of considerable numbers of granulocytes, suggesting either an indispensible role for macrophages and the factors activating them in the control of infection in vivo, or a critical role for GM-CSF in the activation of these granulocytes.
Mice deficient in single or multiple hematopoietic growth factors are an informative model for defining the overlapping and unique roles of these regulators in vivo. Studies of mice deficient in these and other hematopoietic growth factors should significantly further the understanding of their physiologically relevant roles.
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